[Form 4] BrightView Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

BrightView Holdings insider filing: Director Mara E. Swan received 1,958 shares of BrightView common stock on 09/30/2025 as vested director compensation in lieu of cash at an indicated price of $13.40 per share. After the grant the reporting person beneficially owns 115,933 shares. The Form 4 was filed as a single reporting person filing and indicates the acquisition was routine director compensation; the filing was signed by an attorney-in-fact on 10/01/2025.

Insights

Financial Analyst

TL;DR Routine equity grant to a director; small issuance relative to a public company’s float and not likely material to financials.

The transaction shows a director accepted 1,958 vested shares as compensation at $13.40 per share, increasing reported beneficial ownership to 115,933 shares. This is recorded on Form 4 to satisfy Section 16 reporting. There are no indications of option exercises, derivative transactions, or disposals in this filing. From a financial perspective, director equity compensation is a common nondilutive or modestly dilutive mechanism depending on company practices; this filing itself does not disclose changes to overall share count or executive compensation policy.

Corporate Governance Expert

TL;DR Standard director equity vesting disclosure; governance transparency requirements met by timely Form 4 filing.

The Form 4 documents vested shares issued to a director in lieu of cash, which is a common board compensation practice. The filing identifies the reporting person, relationship as director, transaction date, number of shares acquired, price per share, and resulting beneficial ownership. The signature by an attorney-in-fact indicates procedural completion. No departures from routine governance disclosures are evident in the submission.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

SWAN MARA E

(Last) (First) (Middle)

C/O BRIGHTVIEW HOLDINGS, INC.

980 JOLLY ROAD, SUITE 300

(Street)

BLUE BELL PA 19422

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BrightView Holdings, Inc. [ BV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		A(1)		1,958	A	$13.4	115,933	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents vested shares of Issuer common stock issued as director compensation in lieu of cash.

	/s/ Jonathan M. Gottsegen, as Attorney-in-Fact	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.